| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/29/2006 | EP1638574A2 New pharmaceutical uses of staurosporine derivatives |
| 03/29/2006 | EP1638573A2 Use of selective cyclooxygenase-2 inhibitors for the treatment of endometriosis |
| 03/29/2006 | EP1638572A1 Use of roscovitine for treating lymphocytic leukemia |
| 03/29/2006 | EP1638571A1 Combination comprising a cdk inhibitor and a topoisomerase i inhibitor for the treatment of cancer and other proliferative diseases |
| 03/29/2006 | EP1638570A1 Pyrimidine derivatives as cannabinoid receptor ligands |
| 03/29/2006 | EP1638569A1 Use of brimonidine for preventing and reducing the severity of stress-associated conditions |
| 03/29/2006 | EP1638568A2 Indole, azaindole and related heterocyclic n-substituted piperazine derivatives |
| 03/29/2006 | EP1638567A1 Composition comprising a pulmonary surfactant and a pde5 inhibitor for the treatment of lung diseases |
| 03/29/2006 | EP1638566A2 Sulfonamide substituted imidazoquinolines |
| 03/29/2006 | EP1638565A2 Substituted piperidine compounds and methods of their use |
| 03/29/2006 | EP1638563A1 Treatment for alzheimer' s disease and related conditions |
| 03/29/2006 | EP1638562A1 Use of tripolidine in providing refreshedness on waking |
| 03/29/2006 | EP1638561A1 Sponge toxins |
| 03/29/2006 | EP1638559A1 Use of pyrazolopyridines for the treatment of cognitive deficits |
| 03/29/2006 | EP1638558A2 Pharmaceutical composition comprising a macrolide immunomodulator |
| 03/29/2006 | EP1638555A1 Substituted 5-membered ring compounds and their use |
| 03/29/2006 | EP1638554A1 Compositions comprising balaglitazone and further antidiabetic compounds |
| 03/29/2006 | EP1638553A1 New use i |
| 03/29/2006 | EP1638552A2 Use of (3.2.0) heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases |
| 03/29/2006 | EP1638551A2 Immunosuppressant compounds and compositions |
| 03/29/2006 | EP1638550A1 Coumarin derivatives for the treatment of ophthalmic disorders |
| 03/29/2006 | EP1638549A2 Novel antibacterial agents |
| 03/29/2006 | EP1638548A1 Preventing atrial fibrillation (af) with the use of statin drugs |
| 03/29/2006 | EP1638547A1 Composition for preventing urinary system infections |
| 03/29/2006 | EP1638546A1 Use of alpha-ketoglutaric acid for the treatment of malnutrition or high plasma glucose condition |
| 03/29/2006 | EP1638545A1 Combination comprising s-[2-([[1-(2-ethylbutyl)cyclohexyl]carbonyl]amino)phenyl]2-methylpropanethioate and an hmg coa reductase inhibitor |
| 03/29/2006 | EP1638544A2 Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions |
| 03/29/2006 | EP1638543A2 Synergistic combinations of a macrolide t-cell modulator or immunosuppressant and a retinoid |
| 03/29/2006 | EP1638542A1 Use of n-alkanols as activators of the cftr channel |
| 03/29/2006 | EP1638540A2 Pyrazolidinedione derivatives and their use as platelet aggregation inhibitors |
| 03/29/2006 | EP1638539A1 Pharmaceutical compositions comprising ph-sensitive block copolymers and a hydrophobic drug |
| 03/29/2006 | EP1638537A1 Tamsulosin core with a coating of polyvinylpyrrolidone and polyvinylacetate |
| 03/29/2006 | EP1638536A2 Implantable polymeric device for sustained release of nalmefene |
| 03/29/2006 | EP1638532A1 Flupirtin injectable galenic form |
| 03/29/2006 | EP1638528A2 Pharmaceutical composition and method for alleviating side effects of estrogen replacement therapy |
| 03/29/2006 | EP1638526A1 Method of treating acute coronary syndromes |
| 03/29/2006 | EP1638525A2 Inhalable formulations for treating pulmonary hypertension and methods of using same |
| 03/29/2006 | EP1638524A1 Composition and method for the treatment of water related ear disorders |
| 03/29/2006 | EP1638520A2 Solvates of cefprozil |
| 03/29/2006 | EP1638518A1 Oral cereal beta glucan compositions |
| 03/29/2006 | EP1638509A2 Thermally stable crystalline epirubicin hydrochloride and method of making the same |
| 03/29/2006 | EP1638506A2 Topical antiviral therapeutic and prophylactic treatment of adenoviruses and their associated diseases |
| 03/29/2006 | EP1638505A2 Amphiphilic pyridinium compounds, method of making and use thereof |
| 03/29/2006 | EP1638492A2 Preoperative treatment of post operative pain |
| 03/29/2006 | EP1638418A1 Amino acid supplementation for a healthy microbiota ecosystem |
| 03/29/2006 | EP1638417A1 Combinations of vasoprotective agents and formulations containing them |
| 03/29/2006 | EP1638403A1 Control of protozoa and protozoan cysts that harbor legionella |
| 03/29/2006 | EP1572707B1 Novel aromatic fluoroglycoside derivatives, pharmaceutical products containing said compounds and the use thereof |
| 03/29/2006 | EP1539745B1 N-aryl-2-oxazolidinones and their derivatives |
| 03/29/2006 | EP1523311B1 Calcium lactate and whey permeate for lowering the triglyceride level |
| 03/29/2006 | EP1501806B1 Preparations for the topical application of anti-androgenically active substances |
| 03/29/2006 | EP1492792B1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino¬4,5-b|indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 03/29/2006 | EP1482934B1 2-methylthiazolidine-2,4-dicarboxylic acid and the salts thereof used for the treatment of neurodegenerative diseases |
| 03/29/2006 | EP1476190B1 Amino-substituted hypocrellins for use as sonosensitizers |
| 03/29/2006 | EP1467998B1 Tetracyclic heterocompounds as estrogen receptor modulators |
| 03/29/2006 | EP1461083B1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors |
| 03/29/2006 | EP1443917B1 Tamsulosin tablets |
| 03/29/2006 | EP1434576A4 Method of alleviating pain |
| 03/29/2006 | EP1425270B1 Methods and intermediates for preparing 4-aminoquinoline cetp inhibitors |
| 03/29/2006 | EP1414408B1 Composition comprising paroxetine and a pharmaceutically acceptable glycyrrhizinate salt |
| 03/29/2006 | EP1395563B1 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods |
| 03/29/2006 | EP1385496A4 Use of compositions for treating rosacea |
| 03/29/2006 | EP1379253B1 Methods of making and pharmaceutical formulations comprising 7alpha,11beta-dimethyl-17beta-hydroxyestra-4, 14-dien-3-one and 17 esters thereof |
| 03/29/2006 | EP1379234B1 Halogenated aminobenzophenones and aminobenzoylpyridines as inhibitors of il-1 and tnf |
| 03/29/2006 | EP1347765B1 Dermatological aqueous formulations containing clindamycin and a water soluble zinc salt |
| 03/29/2006 | EP1332137B1 Treatment of gastrointestinal stromal tumors |
| 03/29/2006 | EP1331934B1 Ppar-alpha,beta activators for treating alopecia areata and vitiligo |
| 03/29/2006 | EP1330453B1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 03/29/2006 | EP1303270B1 Method for treating cryptorchidism |
| 03/29/2006 | EP1283700B1 Sustained release pharmaceutical compositions for parenteral administration of hydrophilic compounds |
| 03/29/2006 | EP1265483B1 Use of phenylethylamine derivatives for the anitmicrobial treatment of surfaces |
| 03/29/2006 | EP1256587B1 Novel pseudoerythromycin derivatives |
| 03/29/2006 | EP1251828A4 Local drug delivery using photosensitizer-mediated and electromagnetic radiation-enhanced vascular permeability |
| 03/29/2006 | EP1251750B1 Improved pediatric formula and methods for providing nutrition and improving tolerance |
| 03/29/2006 | EP1227086B1 1-substituted phenyl-1-(1h-imidazol-4-yl) alcohols, process for producing the same and use thereof |
| 03/29/2006 | EP1226279B1 Modulation of neuroendocrine differentiation by protein 25.1 |
| 03/29/2006 | EP1222266B1 Pca3 messenger rna in benign and malignant prostate tissues |
| 03/29/2006 | EP1214048B1 Use of conjugated linoleic acid (cla) for the topical treatment of cellulite |
| 03/29/2006 | EP1200395B1 Urea derivatives as inhibitors of ccr-3 receptor |
| 03/29/2006 | EP1181376B1 Gene construct for prodrug activation encoding a heterologous, glycosylphophatidylinositol-modified carboxypeptidase g2 and a cell surface targeting signal peptide |
| 03/29/2006 | EP1179342B1 Immediate release medicinal compositions for oral use |
| 03/29/2006 | EP1165050B1 Methods for fine powder formation |
| 03/29/2006 | EP1156789B1 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 03/29/2006 | EP1146884B1 Novel polymer formulations containing perfluorinated compounds for the engineering of cells and tissues for transplantation that improves cell metabolism and survival, and methods for making same |
| 03/29/2006 | EP1124567B1 Buffered compositions for dialysis |
| 03/29/2006 | EP1124565B1 Azido derivatives of beta-l-2'-deoxy-nucleosides for the treatment of hiv infection |
| 03/29/2006 | EP1105105B1 Oral administration form for pyridin-2-ylmethylsulfinyl-1h-benzimidazoles |
| 03/29/2006 | EP1084704B1 Remedies for spinocerebellar ataxia and compositions for treating spinocerebellar ataxia |
| 03/29/2006 | EP1079847B1 Osteoporosis treatment |
| 03/29/2006 | EP1077715B1 Use of rosmarinic acid and derivatives thereof as an immunosuppressant or an inhibitor of sh2-mediated process |
| 03/29/2006 | EP1060180B1 Process for synthesizing carbapenem antibiotics |
| 03/29/2006 | EP1034180B1 Linker nucleoside, and production and use of the same |
| 03/29/2006 | EP1012331B1 Compositions and methods for the delivery of oligonucleotides via the alimentary canal |
| 03/29/2006 | EP0979823B1 Novel amide compounds and drugs containing the same |
| 03/29/2006 | EP0977555B1 Pharmaceutical preparations and methods for their regional administration |
| 03/29/2006 | EP0971585B1 Tetracycline compounds in the treatment of certain types of cancers |
| 03/29/2006 | EP0957887B1 Use of composition and a cosmetic method for reducing or preventing stinging. |
| 03/29/2006 | EP0956023B1 Use of progesterone for treating or reducing ischemia in menopausal women receiving estrogen |
| 03/29/2006 | EP0944722B1 Pituitary-tumor-transforming-genes, and related products |
| 03/29/2006 | EP0932388B1 Dosage form and method for administering drug |